EdgarLookup

Acrivon Therapeutics, Inc. — DEFA14A Filings

3 DEFA14A filings on record

This page lists all DEFA14A filings submitted to the SEC by Acrivon Therapeutics, Inc. (ACRV), sorted by most recent first. Each row links to the full filing on EdgarLookup. Acrivon Therapeutics, Inc. has filed 3 DEFA14A documents with the SEC since 2021. To view all SEC filings by Acrivon Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-Q 144 3 3/A 4 424B4 8-A12B 8-K ARS CERT CORRESP D DEF 14A DEFA14A DEFR14A DRS DRS/A DRSLTR EFFECT FWP S-1 S-1/A S-1MEF S-3 S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
DEFA14A DEFA14A 0000950170-25-058356 Apr 25, 2025 —
DEFA14A DEFA14A 0000950170-24-048673 Apr 26, 2024 —
DEFA14A DEFA14A 0000950170-23-016272 May 1, 2023 —